Ausgabe 17/2007
Inhalt (16 Artikel)
Commentary
Comment on “Adjuvant Therapy in Pancreatic Cancer: A Critical Appraisal”
Paula Ghaneh, Catrin Tudur-Smith, John P. Neoptolemos
Commentary
Adjuvant Therapy in Pancreatic Cancer: A Critical Appraisal — The Authors’ Reply
Helmut Oettle, Peter Neuhaus
Leading Article
Potential Pharmacological Interventions in Polycystic Kidney Disease
Amirali Masoumi, Berenice Reed-Gitomer, Catherine Kelleher, Robert W. Schrier
Review Article
Crohn’s Disease
Julián Panés, Fernando Gomollón, Carlos Taxonera, Joaquin Hinojosa, Juan Clofent, Vilar Nos
Review Article
Pharmacotherapy for Oesophagogastric Cancer
Christopher Jackson, Naureen Starling, Yu Jo Chua, David Cunningham
Adis Drug Profile
Delayed-Release Multi Matrix System (MMX™) Mesalazine
Paul L. McCormack, Dean M. Robinson, Caroline M. Perry
Adis Drug Profiles
Delayed-Release Multi Matrix System (MMX™) Mesalazine in Ulcerative Colitis
Åke Nilsson
Adis Drug Profiles
Delayed-Release Multi Matrix System (MMX™) Mesalazine in Ulcerative Colitis
Cosimo Prantera
Adis Drug Profiles
Imatinib in Relapsed or Refractory Philadelphia Chromosome-Positive Acute Lymphoblastic Leukaemia
Joseph Brandwein
Adis Drug Profiles
Imatinib in Relapsed or Refractory Philadelphia Chromosome-Positive Acute Lymphoblastic Leukaemia
Ronan Swords
Adis Drug Profiles
Imatinib in Relapsed or Refractory Philadelphia Chromosome-Positive Acute Lymphoblastic Leukaemia
Barbara Wassmann